607 related articles for article (PubMed ID: 9204307)
1. Brucellosis: an overview.
Corbel MJ
Emerg Infect Dis; 1997; 3(2):213-21. PubMed ID: 9204307
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
3. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
4. Rough vaccines in animal brucellosis: structural and genetic basis and present status.
Moriyón I; Grilló MJ; Monreal D; González D; Marín C; López-Goñi I; Mainar-Jaime RC; Moreno E; Blasco JM
Vet Res; 2004; 35(1):1-38. PubMed ID: 15099501
[TBL] [Abstract][Full Text] [Related]
5. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
[TBL] [Abstract][Full Text] [Related]
6. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.
Godfroid J; Cloeckaert A; Liautard JP; Kohler S; Fretin D; Walravens K; Garin-Bastuji B; Letesson JJ
Vet Res; 2005; 36(3):313-26. PubMed ID: 15845228
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
8. Brucella melitensis infection in sheep: present and future.
Garin-Bastuji B; Blasco JM; Grayon M; Verger JM
Vet Res; 1998; 29(3-4):255-74. PubMed ID: 9689741
[TBL] [Abstract][Full Text] [Related]
9. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
11. Improved performance of Brucella melitensis native hapten over Brucella abortus OPS tracer on goat antibody detection by the fluorescence polarization assay.
Ramírez-Pfeiffer C; Díaz-Aparicio E; Rodríguez-Padilla C; Morales-Loredo A; Alvarez-Ojeda G; Gomez-Flores R
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):223-9. PubMed ID: 18359093
[TBL] [Abstract][Full Text] [Related]
12. An unusual etiology of PUO.
Gogia A; Dugga L; Dutta S
J Assoc Physicians India; 2011 Jan; 59():47-9. PubMed ID: 21751665
[TBL] [Abstract][Full Text] [Related]
13. [Brucellosis at the dawn of the 21st century].
Maurin M
Med Mal Infect; 2005 Jan; 35(1):6-16. PubMed ID: 15695027
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of conventional methods and real-time multiplex polymerase chain reaction for identification and typing of Brucella isolates of human origin].
Cerekci A; Kılıç S; Bayraktar M; Uyanık MH; Yaşar E; Esen B
Mikrobiyol Bul; 2011 Jul; 45(3):392-400. PubMed ID: 21935772
[TBL] [Abstract][Full Text] [Related]
15. Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties.
Czibener C; Rey Serantes DA; Romani AM; Bruno L; Pasquevich KA; Cassataro J; Comerci DJ; Ugalde JE
Vaccine; 2023 May; 41(23):3534-3543. PubMed ID: 37149444
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and potential diagnostic applications of serological cross-reactivities between Brucella and other alpha-proteobacteria.
Delpino MV; Fossati CA; Baldi PC
Clin Diagn Lab Immunol; 2004 Sep; 11(5):868-73. PubMed ID: 15358645
[TBL] [Abstract][Full Text] [Related]
17. Brucellosis: a re-emerging zoonosis.
Seleem MN; Boyle SM; Sriranganathan N
Vet Microbiol; 2010 Jan; 140(3-4):392-8. PubMed ID: 19604656
[TBL] [Abstract][Full Text] [Related]
18. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.
Ko J; Splitter GA
Clin Microbiol Rev; 2003 Jan; 16(1):65-78. PubMed ID: 12525425
[TBL] [Abstract][Full Text] [Related]
19. Implications of laboratory diagnosis on brucellosis therapy.
Al Dahouk S; Nöckler K
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):833-45. PubMed ID: 21810055
[TBL] [Abstract][Full Text] [Related]
20. Brucellosis as a world problem.
Abdussalam M; Fein DA
Dev Biol Stand; 1976; 31():9-23. PubMed ID: 1261753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
